FDA Import Refusal SCS-3440627-3/11/27 — Mylan Spa
The FDA refused shipment SCS-3440627-3/11/27 from Mylan Spa (Italy) on Feb 21, 2019. The refused product falls under Drugs and Biologics — SUMATRIPTAN (ANTIMIGRAINE AGENT). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Feb 21, 2019
- Country
- Italy
- Product Category
- Drugs and Biologics
- Product Code
- 63OCA06 SUMATRIPTAN (ANTIMIGRAINE AGENT)
- Charges
- 75